These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8043483)

  • 61. [Antibodies against the structural and nonstructural components of HCV in i.v. drug abusers].
    Tanzi ML; Zoni R; Bracchi U; Bombarda G; Volpicelli A; Bellelli E
    Ann Ig; 1994; 6(1):13-7. PubMed ID: 7530968
    [No Abstract]   [Full Text] [Related]  

  • 62. Factors influencing Hepatitis C virus sero-prevalence among blood donors in north west Pakistan.
    Khattak MN; Akhtar S; Mahmud S; Roshan TM
    J Public Health Policy; 2008 Jul; 29(2):207-25. PubMed ID: 18523475
    [TBL] [Abstract][Full Text] [Related]  

  • 63. High prevalence of occult hepatitis B in hepatitis C-infected Egyptian children with haematological disorders and malignancies.
    Said ZN; El-Sayed MH; El-Bishbishi IA; El-Fouhil DF; Abdel-Rheem SE; El-Abedin MZ; Salama II
    Liver Int; 2009 Apr; 29(4):518-24. PubMed ID: 19192168
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Seroprevalence of hepatitis B and C virus infections among Lao blood donors.
    Jutavijittum P; Yousukh A; Samountry B; Samountry K; Ounavong A; Thammavong T; Keokhamphue J; Toriyama K
    Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):674-9. PubMed ID: 17883005
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Distribution of hepatitis C virus infection in the male Turkish population.
    Coskun O; Erdem H; Besirbellioglu BA; Eyigun CP
    Int J Infect Dis; 2006 Nov; 10(6):481. PubMed ID: 16997590
    [No Abstract]   [Full Text] [Related]  

  • 66. [Prevalence of hepatitis C virus antibodies in homosexual men].
    Domínguez A; Vidal J; Bruguera M; Salleras L
    Med Clin (Barc); 1994 Apr; 102(12):478-9. PubMed ID: 7516034
    [No Abstract]   [Full Text] [Related]  

  • 67. Seroprevalence and significance of antibodies to hepatitis C virus in pediatric patients with malignant diseases.
    Schneppenheim R; Rautenberg P; Behnke H; Vietor K
    Klin Padiatr; 1991; 203(4):273-5. PubMed ID: 1658430
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Detection of antibodies against the hepatitis C virus in Cuban blood donors].
    Rivero RA; Yamaguchi K; Hidalgo-Gato R; Martínez M; Hernández P; Ballester JM
    Sangre (Barc); 1992 Aug; 37(4):301. PubMed ID: 1325074
    [No Abstract]   [Full Text] [Related]  

  • 69. [The serodiagnosis of viral hepatitis C and B in different population groups].
    Somova AV; Golosova TV; Margolina AN; Bagriantseva SIu
    Vopr Virusol; 1992; 37(4):191-3. PubMed ID: 1335191
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [The C virus in Africa].
    Niang A; Klotz F
    Med Trop (Mars); 1993; 53(1):101-4. PubMed ID: 7685056
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [The incidence of detecting antibodies to the hepatitis C virus in different population groups in the USSR].
    Viazov SO; Kuzin SN; Orlova NG; Shakhgil'dian IV; Andriutsa KA; Paladi NE; Asfandiiarova NS; Buriev AIa; Savin EA; Bryzgalov SP
    Vopr Virusol; 1991; 36(5):366-8. PubMed ID: 1725075
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Horizontal transmission of hepatitis C virus to family members of infected polytransfused pediatric patients].
    Mangiagli A; Campisi S; Piazza L; Lo Monaco D
    Pediatr Med Chir; 1995; 17(2):151-2. PubMed ID: 7541913
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [The detection of antibodies to the hepatitis C virus and to HBsAg in donors with viral hepatitis and cancerous diseases in the Republic of Moldova].
    Kostritsa SS; Kuzin SN; Khukhlovich PA; Shakhgil'dian IV; Doroshenko NV; Blinov VM; Loparen VN; Sukhanova LL; Gol'tsov VA; Drobeniuk ZhA
    Vopr Virusol; 1994; 39(2):93-4. PubMed ID: 8017065
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Post-transfusional hepatitis].
    González A; Esteban JI
    Sangre (Barc); 1993 Jun; 38(3):193-200. PubMed ID: 7692610
    [No Abstract]   [Full Text] [Related]  

  • 75. [Seroprevalence of hepatitis C virus in hemophiliacs in Switzerland].
    Perret BA; Senn M; Affentranger P; Poorbeik M; Burckhardt JJ; Morell A
    Schweiz Med Wochenschr; 1993 Jan; 123(3):79-81. PubMed ID: 7678942
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Relative risk of hepatitis C virus transmission in polytransfused patients].
    Schujman L; Lavitula S; Maris Acebal S; Suita GR; Montero A
    Medicina (B Aires); 1994; 54(3):199-202. PubMed ID: 7854084
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Post-transfusion hepatitis C in Finland].
    Ebeling F
    Duodecim; 1993; 109(8):709. PubMed ID: 7520387
    [No Abstract]   [Full Text] [Related]  

  • 78. Donor hepatitis C antibody virus testing in renal transplantation.
    Mendez R; Aswad S; Bogaard T; Khetan U; Asai P; Martinez A; Flores N; Mendez RG
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1487-90. PubMed ID: 7680167
    [No Abstract]   [Full Text] [Related]  

  • 79. [The prevalence of anti-HCV positivity among blood donors in Asturias. A clinical-epidemiologic study].
    Suárez A; Rodríguez M; Riestra S; Navascués CA; San Román FS; Otero L; Martínez A; Rodrigo L
    Med Clin (Barc); 1994 Nov; 103(16):606-10. PubMed ID: 7996916
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [The prevalence of HCV antibodies in 3 groups with distinct patterns of sexual activity].
    Riestra S; Rodríguez M; Palacios V; Cárcaba V; Suárez A; Navascués CA; Pérez R; Rodrigo L
    Rev Esp Enferm Dig; 1992 May; 81(5):359-62. PubMed ID: 1319721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.